Table 1 Age-specific incidence of pneumococcal-related diseases, hospitalizations and GP consultations in Turkey per 100,000 population
From: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
Age group (years) | ||||||
|---|---|---|---|---|---|---|
Pneumococcal meningitis | Pneumococcal bacteremia | All-cause pneumonia (hospitalized) | All-cause pneumonia (GP) | AOM (hospitalized) | AOM (GP) | |
<1 | 14.6 | 45 | 339 | 1,356 | 357.1 | 33,000 |
1-<2 | 10 | 25 | 132 | 528 | 357.1 | 33,000 |
2-<3 | 5 | 25 | 21 | 84 | 357.1 | 33,000 |
3-<4 | 5 | 12.5 | 21 | 84 | 357.1 | 33,000 |
4-<5 | 5 | 12.5 | 21 | 84 | 357.1 | 33,000 |
5-<10 | 1.2 | 0.5 | 15.5 | 62.4 | 44.0 | 20,189 |